-
Kevin Alexander
CardiologyWild-Type ATTR: Significance and Impact - 12 day(s) agoDear readers, This week, my collection on transthyretin amyloid (ATTR) continues with a discussion from Dr. Esther Gonzalez Lopez. In the study, she discusses the…
Cardiology With Kevin M. Alexander, MD, FACC, FHFSA
CardiologyDr. Alexander is an advanced heart failure-trained cardiologist and an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine. He specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.
-
Kevin Alexander
CardiologyRadcliffe Cardiology Looks Toward Future of ATTR - 12 day(s) agoDear readers, Thank you for taking the time to read this series on ATTR. In my final collection, I want to highlight a few topics…
-
Kevin Alexander
CardiologyDear readers, In this series, I will feature a collection of content focused on the rare, yet potentially fatal heart condition transthyretin amyloid cardiomyopathy (ATTR-CM).…